Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8

Tissue Antigens

Volumn 51, Issue 3, 1998, Pages 281-286

  Sanjeevi, C B ^a   Hagopian, W A ^b   Landin Olsson, M ^c   Kockum, I ^a   Woo, W ^b   Palmer, J P ^e   Lernmark, A ^a,b   Dahlquist, G ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF WASHINGTON   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

DQ; GAD65 autoantibodies; HLA DR; ICA; ICA512 autoantibodies; IDDM; Insulin autoantibodies

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN; HLA DR4 ANTIGEN; INORGANIC PYROPHOSPHATASE; INSULIN ANTIBODY;

ADOLESCENT; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; GENE LOCUS; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SWEDEN;

EID: 0031935660     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03103.x     Document Type: Article

References (40)

1. LaPorte RE, Tajima N, Åkerblom HK et al. Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries. Diabetes Care 1985: 8: 101-107.
2. Dahlquist G. Environmental risk factors in human type 1 diabetes - an epidemiological perspective. Diabetes Metab Rev 1995: 11: 37-46.
3. Palmer JP, Lernmark Å. Pathphysiology of type 1 (insulin-dependent) diabetes. New York: Elsevier, 1990.
4. Eisenbarth GS. Type 1 diabetes mellitus. A chronic autoimmune disease. New Engl J Med 1986: 314: 1360-1368.
5. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965: 14: 619-633.
6. Foulis AK, McGill M, Farquharson A. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man - macrophages, lymphocytes, and interferon-λ containing cells. J Pathol 1991: 165: 97-103.
7. Lernmark Å, Klöppel G, Stenger D et al. Heterogeneity of the human islet pathology in newly diagnosed childhood insulin-dependent diabetes mellitus. Macrophage infiltrations and expression of HLA-DQ and glutamic acid decarboxylase. Virchows Arch 1995: 425: 631-640.
8. Roep B, Duinkerken G, Schreuder G, Kolb H, DeVries R, Martin S. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent onset insulin-dependent diabetes mellitus. Eur J Immunol 1996: 26: 1285-1289.
9. Davies JL, Kawaguchi Y, Bennett ST et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994: 371: 130-136.
10. Sanjeevi CB, Lybrand TP, Landin-Olsson M et al. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 1994: 44: 110-119.
11. Sanjeevi CB, Lybrand T, DeWeese C et al. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of insulin-dependent diabetes mellitus. Diabetes 1995: 44: 125-131.
12. Sanjeevi CB, Landin-Olsson M, Kockum I, Dahlquist G, Lernmark Å. Effects of the second haplotype on the association with childhood insulin-dependent diabetes mellitus. Tissue Antigens 1995: 45: 148-152.
13. Sanjeevi CB, Höök P, Landin-Olsson M et al. DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes. Tissue Antigens 1996: 47: 275-283.
14. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974: 2 (892): 1279-1283.
15. Landin-Olsson M, Palmer JP, Lernmark Å et al. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly diagnosed diabetic and matched control children. Diabetologia 1992: 35: 1068-1073.
16. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982: 298: 167-169.
17. Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarbuxylase. Nature 1990: 347: 151-156.
18. Karlsen AE, Hagopian WA, Grubin CE et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci U S A 1991: 88: 8337-8341.
19. r isoform of glutamic acid decarboxylase. Diabetes 1993: 42: 631-636.
20. Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983: 222: 1337-1339.
21. Verge C, Gianani R, Kawasaki E et al. Prediction of Type 1 diabetes in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512 autoantibodies. Diabetes 1996: 45: 926-933.
22. Bingley P, Christie M, Bonifacio E et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994: 43: 1304-1310.
23. Hagopian W, Sanjeevi CB, Kockum I et al. Glutamate decarboxylase-, insulin-, and islet cell antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995: 95: 1505-1511.
24. Serjeantson SW, Kohonen-Corish MRJ, Rowley MJ, Mackay IR, Knowles W, Zimmer P. Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992: 35: 996-1001.
25. Serjeantson S, Court J, Mackay I et al. HLA-DQ) genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients. Hum Immmunol 1993: 38: 97-104.
26. Altmann D, Sansom D, Marsch S. What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 1991: 12: 267-271.
27. Dahlquist G, Blom L, Lönnberg G. The Swedish Childhood Diabetes Study - a multivariate analysis of risk determinants for diabetes in different age groups. Diabetologia 1991: 34: 757-762.
28. Sanjeevi CB, Seshiah V, Möller E, Olerup O. Different genetic background for Type 1 diabetes and malnutrition-related diabetes in South Indians. Diabetologia 1992: 35: 283-286.
29. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark Å. HLA-DQ primarily confers protection and HLA-DR susceptibility in Type 1 (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 1993: 53: 150-167.
30. Landin-Olsson M, Sundkvist G, Lernmark Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987: 30: 327-332.
31. Rabin D, Pleasic S, Palmer-Crocker R, Shapiro J. Cloning and expression of IDDM specific human autoantigens. Diabetes 1992: 41: 183-186.
32. Lan M, Lu J, Goto Y, Notkins A. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994: 13: 505-514.
33. Miettinen OS. The estimability and estimation on case reference studies. Am J Epidemiol 1976: 103: 226-235.
34. Nerup J, Platz P, Anderssen OO. HLA antigens and diabetes mellitus. Lancet 1974: ii: 864-866.
35. Farid NR, Sampson L, Noel P, Barnard JM, Davis AJ, Hillman DA. HLA-D-related (DRw) antigens in juvenile diabetes mellitus. Diabetes 1979: 28: 552-7.
36. Michelsen B, Lernmark Å. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest 1987: 79: 1144-1152.
37. Caillat-Zucman S, Daniel S, Djilali-Saiah I et al. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus. Hum Immunol 1995: 44: 80-87.
38. Esposito L, Lampasona V, Bosi E, Poli F, Ferrari M, Bonifacio E. HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus. Diabetologia 1995: 38: 968-74.
39. Genovese S, Bonfanti R, Bazzigaluppi E et al. Association of IA-2 autoantibodies with HLA-DR4 phenotypes in IDDM. Diabetologia 1996: 39: 1223-1226.
40. Nag B, Mukku P, Arimilli S, Phan D, Deshpande S, Winkelhake J. Antigenic peptide binding to MHC class II molecules. Mol Immunol 1994: 31: 1161-1168.